Early Access — free while we kick the tires
EdgarHawk

INDV Indivior Pharmaceuticals, Inc. Insider Trading

Latest: CFO Sold $1.4M of Shares · Jun 2026
1 filing analyzed · Latest 2026-06-10
Insider buys
0
Insider sells
1
Unique insiders
1
Direction
Net selling
June 2026
2026-06-10
low
Ryan Preblick Sell
Chief Financial Officer
36,000 shares
$1,357,200
@ $37.70
Significance 3/10

CFO Ryan Preblick sold 36,000 INDV shares at $37.70 via pre-arranged 10b5-1 plan; retains 284,751 shares

This sale of 36,000 shares (36.0K shares) for $1,357,200.00 ($1.4M) was executed under a 10b5-1 trading plan adopted on 2026-03-06, making it a scheduled transaction rather than a discretionary choice by Preblick. The CFO retains 284,751 shares (284.8K shares) post-transaction, representing a -11.2% reduction in his holdings. With current stock price at $38.26, the transaction occurred at $37.70, near recent trading levels, and the company maintains solid operational performance with $317,000,000.00 ($317.0M) in latest-quarter revenue and a P/E of 18.48.

Get alerts for INDV

Add INDV to your watchlist and we'll email you when an insider files a Form 4 — with our AI's significance score and a plain-English read of what it means.

Sign up — free during early access